Kiniksa Pharmaceuticals Ltd
KNSA
$78.59-1.69%
End of day · as of Oct 16, 2026, 6:00 PM ET
Mkt cap
$3.73B
EV/Sales
5.25
P/E ratio
N/A
FY2025 Revenue
$677.56M
EPS (9mo ended 2025-09-30)
$0.57
Gross Margin (FY2025)
88.54%
Profit Margin (FY2025)
8.71%
Beta
0.12
Div yield
N/A
Sector
Healthcare
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B.
Use this KNSA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KNSA income, balance, and cash tables.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue for Dec 31, 2025 was $677.6M. Net income was $59.0M. Statements: https://lician.com/financials/knsa
Kiniksa Pharmaceuticals Ltd (KNSA) market capitalization is $3.73B on the latest cached snapshot.
Kiniksa Pharmaceuticals Ltd (KNSA) cached previous close $79.94; day range $78.56 – $79.94; volume 445,701. Session quote: https://lician.com/quote/knsa
Kiniksa Pharmaceuticals Ltd (KNSA) latest cached earnings event is "KNSA earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached KNSA filing is 8-K · Jul 28, 2026. Filings: https://lician.com/sec/knsa